Main navigation
- Programs
- Subjects
- Universities
- Destinations
- Advice
Stanford University launched its Cancer Biology Ph.D. Program in 1978. Over the last thirty years, scientific breakthroughs have revolutionized our comprehension of cancer, uncovering oncogenes, tumor suppressor genes, DNA repair mechanisms, cell cycle control, angiogenesis, hypoxia responses, and metastatic processes. Advanced analytical techniques like gene expression arrays, protein arrays, and tissue arrays have further refined cancer classification. These fundamental and clinical discoveries have paved the way for targeted cancer treatments through chemotherapy and immunotherapy. Stanford's distinctive campus layout—with its Medical School, Humanities and Sciences, and Engineering Schools all within close proximity—creates an ideal setting for collaborative cancer research. The program aims to equip students with the knowledge and skills to advance this dynamic field. First-year studies offer comprehensive training in cancer's molecular, genetic, cellular, and pathological dimensions, alongside exposure to modern clinical practices. Students also complete three lab rotations during this period. By their second year, participants select a research advisor and commence dissertation work, with qualifying exams due by year's end. The program hosts an annual Cancer Biology Conference for student presentations and faculty engagement, typically culminating in degree completion within four to five years.